304 related articles for article (PubMed ID: 22727093)
21. Investigating the antifungal activity and mechanism(s) of geraniol against Candida albicans strains.
Leite MC; de Brito Bezerra AP; de Sousa JP; de Oliveira Lima E
Med Mycol; 2015 Apr; 53(3):275-84. PubMed ID: 25480017
[TBL] [Abstract][Full Text] [Related]
22. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
Guo N; Ling G; Liang X; Jin J; Fan J; Qiu J; Song Y; Huang N; Wu X; Wang X; Deng X; Deng X; Yu L
Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of terpenes against Candida albicans and ultrastructural alterations.
Martínez A; Rojas N; García L; González F; Domínguez M; Catalán A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Nov; 118(5):553-9. PubMed ID: 25442491
[TBL] [Abstract][Full Text] [Related]
24. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study.
Mansourian A; Boojarpour N; Ashnagar S; Momen Beitollahi J; Shamshiri AR
J Mycol Med; 2014 Dec; 24(4):e163-8. PubMed ID: 25442923
[TBL] [Abstract][Full Text] [Related]
25. Impact of pH on the antifungal susceptibility of vaginal Candida albicans.
Liu W; Zhang X; Liu Z; Luo X
Int J Gynaecol Obstet; 2011 Sep; 114(3):278-80. PubMed ID: 21696733
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids.
Tobudic S; Forstner C; Schranz H; Poeppl W; Vychytil A; Burgmann H
Mycoses; 2013 Nov; 56(6):623-30. PubMed ID: 23551835
[TBL] [Abstract][Full Text] [Related]
27. Antifungal activity of Punicalagin-nystatin combinations against Candida albicans.
da Silva RA; Ishikiriama BLC; Ribeiro Lopes MM; de Castro RD; Garcia CR; Porto VC; Santos CF; Neppelenbroek KH; Lara VS
Oral Dis; 2020 Nov; 26(8):1810-1819. PubMed ID: 32583467
[TBL] [Abstract][Full Text] [Related]
28. The action of miconazole of the growth of Candida albicans.
Van Den Bossche H; Willemsens G; Van Cutsem JM
Sabouraudia; 1975 Mar; 13 Pt 1():63-73. PubMed ID: 1091999
[TBL] [Abstract][Full Text] [Related]
29. Antifungal activities and action mechanisms of compounds from Tribulus terrestris L.
Zhang JD; Xu Z; Cao YB; Chen HS; Yan L; An MM; Gao PH; Wang Y; Jia XM; Jiang YY
J Ethnopharmacol; 2006 Jan; 103(1):76-84. PubMed ID: 16169173
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D
Bouzid D; Merzouki S; Bachiri M; Ailane SE; Zerroug MM
J Mycol Med; 2017 Mar; 27(1):79-82. PubMed ID: 27865660
[TBL] [Abstract][Full Text] [Related]
31. In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect.
Gunderson SM; Hoffman H; Ernst EJ; Pfaller MA; Klepser ME
Antimicrob Agents Chemother; 2000 Oct; 44(10):2887-90. PubMed ID: 10991881
[TBL] [Abstract][Full Text] [Related]
32. Effect of Schinus terebinthifolius on Candida albicans growth kinetics, cell wall formation and micromorphology.
Alves LA; Freires Ide A; Pereira TM; de Souza A; Lima Ede O; de Castro RD
Acta Odontol Scand; 2013; 71(3-4):965-71. PubMed ID: 23294177
[TBL] [Abstract][Full Text] [Related]
33. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
34. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
[TBL] [Abstract][Full Text] [Related]
35. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.
Melkoumov A; Goupil M; Louhichi F; Raymond M; de Repentigny L; Leclair G
J Antimicrob Chemother; 2013 Sep; 68(9):2099-105. PubMed ID: 23620465
[TBL] [Abstract][Full Text] [Related]
36. Antifungal activity of black tea polyphenols (catechins and theaflavins) against Candida species.
Sitheeque MA; Panagoda GJ; Yau J; Amarakoon AM; Udagama UR; Samaranayake LP
Chemotherapy; 2009; 55(3):189-96. PubMed ID: 19420933
[TBL] [Abstract][Full Text] [Related]
37. Use of alcohol vinegar in the inhibition of Candida spp. and its effect on the physical properties of acrylic resins.
de Castro RD; Mota AC; de Oliveira Lima E; Batista AU; de Araújo Oliveira J; Cavalcanti AL
BMC Oral Health; 2015 Apr; 15():52. PubMed ID: 25928798
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of activity and toxicity of Nystatin-Intralipid.
Semis R; Kagan S; Berdicevsky I; Polacheck I; Segal E
Med Mycol; 2013 May; 51(4):422-31. PubMed ID: 23088298
[TBL] [Abstract][Full Text] [Related]
39. Antifungal efficacy of 5.25% sodium hypochlorite, 2% chlorhexidine gluconate, and 17% EDTA with and without an antifungal agent.
Chandra SS; Miglani R; Srinivasan MR; Indira R
J Endod; 2010 Apr; 36(4):675-8. PubMed ID: 20307743
[TBL] [Abstract][Full Text] [Related]
40. In vitro effectiveness of mouthrinses against Candida albicans.
Nakamoto K; Tamamoto M; Hamada T
Int J Prosthodont; 1995; 8(5):486-9. PubMed ID: 8595107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
